Bacterial Infection and Immunity - PowerPoint PPT Presentation

1 / 39
About This Presentation
Title:

Bacterial Infection and Immunity

Description:

Members of the resident flora in the intestinal tract ... TH1. Components of the Immune System. Humoral. Cellular. Humoral. Cellular. Specific. Nonspecific ... – PowerPoint PPT presentation

Number of Views:354
Avg rating:3.0/5.0
Slides: 40
Provided by: gxk
Category:

less

Transcript and Presenter's Notes

Title: Bacterial Infection and Immunity


1
Bacterial Infection and Immunity
  • Xiao-Kui GUO

2
Symbioses
  • Commensalism one partner benefits and the other
    is neither harmed nor benefited.
  • Mutualism both partners benefit.
  • Parasitism one partner benefits at the expense
    of the other.

3
Role of the resident flora
  • Members of the resident flora in the intestinal
    tract synthesize vitamin K and aid in the
    absorption of nutrients.
  • Members of the resident flora on mucous membranes
    and skin may prevent colonization by pathogens
    and possible disease through bacterial
    interference.
  • The normal flora may antagonize other bacteria
    through the production of substances which
    inhibit or kill nonindigenous species.
  • The normal flora stimulates the development of
    certain tissues, i.e., the caecum and certain
    lymphatic tissues (Peyer's patches) in the GI
    tract
  • The normal flora stimulate the production of
    cross-reactive antibodies.

4
  • Hospital acquired infection Infections acquired
    during hospital stays.
  • Pathgen A microorganism capable of causing
    sisease.
  • Nonpathogen A microorganism that does not cause
    disease may be part of the normal flora.
  • Opportunistic pathogen An agent capable of
    causing disease only when the hosts resistance
    is impaired (ie, when the patient is
    immunocompromised).
  • Pathogenicity The ability of an infectious agent
    to cause disease
  • Virulence The quantitative ability of an agent
    to cause disease. Virulent agents cause disease
    when introduced into the host in small numbers.
    Virulence involves invasion and toxigenicity.
  • LD 50 (age /sex /health /route of entry,
    etc )
  • LD50 The number of pathogens required to cause
    lethal disease in half of the exposed hosts is
    called an LD50.
  • ID50 The number of pathogens required to cause
    disease (or, at least, infection) in half of the
    exposed hosts is called the ID50
  • Adherence(adhesion, attachment) the process by
    which bacteria stick to the surfaces of host
    cells. Once bacteria have entered the body,
    adherence is a major initial step in the
    infection process. The terms adherence, adhesion,
    and attachment are often used interchangeably.
  • Invasion The process whereby bacteria, animal
    parasites, fungi, and viruses enter host cells or
    tissues and spread in the body.
  • Toxigenicity The ability of a microorganism to
    produce a toxin that contributes to the
    development of disease.

5
  • Koch's postulates
  • Isolated
  • diseased not healthy people
  • Growth
  • pure culture
  • Induce disease
  • susceptible animals
  • Re-isolated
  • susceptible animals
  • Kochs Postulates
  • Molecular Kochs Postulates
  • Molecular Guidelines for Establishing Microbial
    Disease Causation

6
Pathogenesis
  • Pathogenesis is a multi-factorial process which
    depends on the immune status of the host, the
    nature of the species or strain (virulence
    factors) and the number of organisms in the
    initial exposure.

7
Source of infection
  • Exogenous infection patient, carrier, diseased
    animal or animal carrier.
  • Endogenous condition most are normal flora,
    cause infection under abnormal condition.

Routes of infection
Transmission
  • Respiratory
  • Gastroenteric
  • Genitourinary tract
  • closely contact
  • insect bitting
  • blood transfusion
  • Parenteral route
  • Mucous membranes
  • Airborne droplets
  • Food
  • Water
  • Sexual contact

8
According to infectious sites
According to infectious state
  • Inapparent or subclinical infection
  • Latent infection
  • Apparent infection cause apparent clinic
    syndrome
  • Carrier state carrier
  • Local infection
  • Generalized or systemic infection
  • Toxemia is the presence of exotoxins in the
    blood.
  • Endotoxemia is the presence of endotoxins in
    the blood.
  • Bacteremia is an invasion of the bloodstream by
    bacteria.
  • Septicemia illness that occurs when poisonous
    substances (toxins) produced by certain bacteria
    enter the bloodstream.
  • Pyemia is caused by pyogenic microorganisms in
    the blood.

9
(No Transcript)
10
BACTERIAL VIRULENCE FACTORS
Environmental signals often control the
expression of the virulence genes. Common signals
includeTemperrature/Iron availability C
diphtheriae /low ion/Osmolality /Growth
phase/pH/Specific ions
11
1. Adherence Factors
1. Tissue tropism 2. Species specificity 3.
Genetic specificity within a species
  • Hydrophobic interactions
  • Electrostatic attractions
  • Atomic and molecular vibrations resulting from
    fluctuating dipoles of similar frequencies
  • Brownian movement
  • Recruitment and trapping by biofilm polymers
    interacting with the bacterial glycocalyx
    (capsule)

12
(No Transcript)
13
(No Transcript)
14
Adhesion
E. coli fimbriae
15
2. Invasion of host cells tissues
16
3. Toxins  
  • Exotoxins
  • Endotoxins
  • Exotoxins
  • Produce in vitro cause food poisoning botulin,
    staphylococcal enterotoxin, etc.
  • Produce in vivo
  • Systematic toxic effects e.g. diphtheria,
    tetanus, and streptococcal erythrogenic toxins.
  • Local toxic effects e.g. cholera, and
    toxigenic E. coli enterotoxins.
  • Antibodies (anti-toxins) neutralize
  • vaccination

17
(No Transcript)
18
(No Transcript)
19
Endotoxins
  • LPS Lipopolysaccharide
  • core or backbone of CHO
  • side chains of CHO "O" antigen
  • Lipid A
  • Cell wall lysis required
  • formaldehyde and heat resistant
  • poor antigen as free molecule
  • Endotoxin effects
  • Fever-pyrogen 1 microgram/ kg
  • Leukopenia and leukocytosis necrosis
  • Shwartzman phenomenon and disseminated
    intravascular coagulation (DIC).
  • Endotoxemia and shock
  • Lethal 1 milligram/ kg Identification Limulcyte
    assay
  • Non-specific inflammation.
  • Cytokine release
  • Complement activation
  • B cell mitogens
  • Polyclonal B cell activators
  • Adjuvants

20
(No Transcript)
21
   Peptidoglycan of Gram-positive bacteria
  • May yield many of the same biologic activities as
    LPS.

22
  4. Enzymes
5. Antiphagocytic factors
  • Tissue-degrading enzymes
  • IgA1 proteases split IgA1, an important
    secretory antibody on mucosal surfaces, and
    inactivate its antibody activity.
  • H. influenzae
  • S. pneumoniae
  • N. gonorrhoeae
  • N. meningitidis
  • Some pathogens evade phagocytosis or leukocyte
    microbicidal mechanisms by adsorbing normal host
    components to their surfaces. A few bacteria
    produce soluble factors or toxins that inhibit
    chemotaxis by leukocytes and thus evade
    phagocytosis.

23
Antiphagocytic Substances
  • 1. Polysaccharide capsules of S. pneumoniae,
    Haemophilus influenzae, Treponema pallidum B.
    anthracis and Klebsiella pneumoniae.
  • 2. M protein and fimbriae of Group A streptococci
  • 3. Surface slime (polysaccharide) produced as a
    biofilm by Pseudomonas aeruginosa
  • 4. O polysaccharide associated with LPS of E.
    coli
  • 5. K antigen (acidic polysaccharides) of E. coli
    or the analogous Vi antigen of Salmonella typhi
  • 6. Cell-bound or soluble Protein A produced by
    Staphylococcus aureus. Protein A attaches to the
    Fc region of IgG and blocks the cytophilic
    (cell-binding) domain of the Ab. Thus, the
    ability of IgG to act as an opsonic factor is
    inhibited, and opsonin-mediated ingestion of the
    bacteria is blocked.

24
Protein A inhibits phagocytosis
immunoglobulin
M protein inhibits phagocytosis
Complement
fibrinogen
M protein
peptidoglycan
25
6. Intracellular pathogenicity
  • Some bacteria live and grow within
    polymorphonuclear cells, macrophages, or
    monocytes by avoiding entry into phagolysosomes
    and living within the cytosol of the phagocyte,
    preventing phagosome-lysosome fusion and living
    within the phagosome, or being resistant to
    lysosomal enzymes and surviving within the
    phagolysosome.

26
7. Antigenic heterogeneity
  • Antigenic type of bacteria may be a marker for
    virulence, related to the clonal nature of
    pathogens, though it may not actually be the
    virulence factor.
  • Some bacteria may make frequent shifts in the
    antigenic form of their surface structures in
    vitro and presumably in vivo, allowing the
    bacteria to evade the hosts immune system.

27
8. The requirement for iron
  • For the host, the iron metabolism denies
    pathogenic bacteria an adequate source of iron
    for growth.
  • For the bacteria, they have developed several
    methods to obtain sufficient iron for essential
    metabolism, e.g., the low-affinity iron
    assimilation system or the high-affinity iron
    assimilation systems.

Bacterial siderophores compete effectively for
Fe3 bound to lactoferrin and transferrin.
28
Development of the Immune System

29
Components of the Immune System
30
Balance between Infection and Immunity
31
Response to Infection
32
Significance of the Immune System
  • Beneficial
  • Protection from Invaders
  • Elimination of Altered Self
  • Detrimental
  • Discomfort (inflammation)
  • Damage to self (autoimmunity)

33
Components of Innate and Adaptive Immunity
physical barriers
skin, gut Villi, lung cilia,etc
none
soluble factors
many protein and non-protein secretions
Immunoglobulins (antibody)
cells
phagocytes, NK cell eosinophils, K cells
T and B lymphocytes
34
(No Transcript)
35
Chemotactic response to inflammatory stimulus
Macrophage Attacking E.coli (SEM x8,800)
36
Adaptive Immunity
37
Characteristics of Innate and Adaptive Immunity
  • Antigen independent
  • Antigen dependent
  • No time lag
  • A lag period
  • Not antigen specific
  • Antigen specific
  • No Immunologic
  • memory
  • Development
  • of memory

38
  • Immunity of extracellular bacterial infection
    antibodies (IgG, IgM, SIgA) phagocytes
    (neutrophils) complement humoral immunity
    mainly.
  • Immunity of intracellular bacterial infection
    cell-mediated immunity (delayed-type
    hypersensitivity, DTH response (DTH) involving
    TH1and macrophages) mainly.

39
INADEQUATE IMMUNE RESPONSES TO INFECTIOUS AGENTS
  • Causes immune suppressionan example is infection
    with HIV, which alters T cell immunity and allows
    further infection with opportunistic pathogens.
  • Release toxins that function as superantigens,
    initially stimulating large numbers of T cells to
    proliferate but, because of the release of
    cytokines from T cells, ultimately suppressing
    the immune response and allowing the pathogen to
    multilply.
  • Evade the immune defenses by altering their
    antigenic structurean example is that influenza
    virus undergoes antigenic variation by two
    mutational mechanisms called antigenic shift and
    antigenic drift that creat new antigenic
    phenotypes which evade the hosts current
    immunity and allow reinfection with the virus.
Write a Comment
User Comments (0)
About PowerShow.com